PJSC Magnit

  • ISIN: US55953Q2021
  • Land: Russland

Nachricht vom 26.11.2021 | 07:59

Magnit obtains leasehold rights for 56 Edelweiss stores in Kazan

26-Nov-2021 / 09:59 MSK
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


MAGNIT obtains leasehold rights for 56 edelweiss stores in kazan


Krasnodar, November 26, 2021: Magnit PJSC (MOEX and LSE: MGNT; the Company, Magnit), one of Russia's leading retailers, announced it has reached an agreement for the long-term leasehold rights for the 56 stores currently operating under the Edelweiss brand in Kazan.

The stores are located in Kazan (the fifth largest city in Russia with approx. 1.3 million inhabitants[1]) representing 25 thousand sq. m. of selling space. The lease rights are planned to be obtained for up to 10 years.

As of September 30, 2021, Magnit operated 265 stores in Kazan including 183 convenience stores, 3 supermarkets and 79 drogeries. The stores align with the Company's format strategy in terms of size and layout and are located in high-quality densely populated areas. The lease of former Edelweiss stores will strengthen Magnit's position in the local market and support its continued development.

According to the agreement the Company plans to obtain leasehold rights in several stages, subject to successful legal and technical due diligence.

Obtainment of the leasehold rights does not require any regulatory or Magnit's Board approval. The stores will be redesigned where relevant and will become operational in several stages under the Magnit brand. In total, the Company plans to open 67 stores in the premises of former Edelweis outlets - 50 convenience stores, 14 drogeries and 3 hard discounters. The stores are scheduled to be opened within 4Q 2021 - 1Q 2022. The redesign will not require significant investment and has no impact on 2021 capital expenditures projections.


Andrey Bodrov

Chief Strategy and Investment Officer


"This agreement further strengthens our competitive position in the fifth largest city in Russia, expanding our presence in high quality and densely populated areas. These additional stores are highly complementary to our existing portfolio and align with our successful growth strategy which combines new store openings with value accretive market share consolidation opportunities".




For further information, please contact:


Dina Chistyak

Head of Investor Relations 

Office: +7 (861) 210 9810 x 15101


Media Inquiries                    Twitter

press@magnit.ru                    @MagnitIR




Note to editors


"Magnit" is one of Russia's leading retailers. Founded in 1994, the company is headquartered in the southern Russian city of Krasnodar. As of September 30, 2021, Magnit operated 45 distribution centers and 25,315 stores in 3,840 cities and towns throughout 7 federal regions of the Russian Federation.

In accordance with the unaudited IFRS 16 management accounts results for 9M 2021, Magnit had revenues of RUB 1,311.5 billion and an EBITDA of RUB 151.4 billion. Magnit's local shares are traded on the Moscow Exchange (MOEX: MGNT) and its GDRs on the London Stock Exchange (LSE: MGNT) and it has a credit rating from Standard & Poor's of BB.




Forward-looking statements


This document contains or may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected sales growth rate and/or store openings are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Magnit as of the date of the statement. All written or oral forward-looking statements attributable to Magnit are qualified by this caution. Magnit does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances.


[1] According to Rosstat as at the beginning of 2021

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021